Combined Mitral and Tricuspid Valve Repair in Rheumatic Valve Disease

153 consecutive patients with rheumatic disease undergoing combined mitral and tricuspid valve repair, mean age 46.0+/-13.2 years. Mitral disease predominantly stenosis (82.3%); 100% had organic tricuspid valve disease (53.6% regurgitation, 46.4% stenosis).

Combined mitral and tricuspid valve repair (mitral repair included commissurotomy in 86.3% and flexible annuloplasty in 70.6%; tricuspid repair included flexible annuloplasty in 44.4%, suture annuloplasty in 13.1%, and commissurotomy in 42.5%)

Early (30-day) mortality, late mortality, and valve reoperationhard clinical